ATLANTHERA has a total of 12 patent applications. Its first patent ever was published in 2011. It filed its patents most often in France, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are RETROPHIN INC, KANEQ PHARMA INC and MI WENJUN.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Hungary | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Special acyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Sugars | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Egorov Maxim | 12 |
#2 | Le Bot Ronan | 12 |
#3 | Goujon Jean-Yves | 10 |
#4 | David Emmanuelle | 6 |
#5 | Grovel Olivier | 2 |
#6 | Pouchus Yves Francois | 2 |
#7 | Petit Fabien | 2 |
#8 | Vansteelandt Marieke | 2 |
Publication | Filing date | Title |
---|---|---|
EP3237015A1 | Hydrosoluble hydroxybisphosphonic doxorubicine derivatives | |
FR2973376A1 | DERIVATIVES USEFUL IN THE TREATMENT OR PREVENTION OF BONE TUMORS | |
FR2973378A1 | BIFUNCTIONAL HYDROXYBISPHOSPHONIC ACID DERIVATIVES |